Clinical Trial Update: Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration [Phase 2]

View source ↗

Summary

A Phase 2 trial exploring darbepoetin for ischemic neonatal stroke to augment regeneration is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Neonatal Stroke
• Neonatal Stroke
• Perinatal Arterial Ischemic Stroke

Drugs mentioned

• Darbepoetin (darbepoetin alfa)

Snippet

Sponsor: UMC Utrecht | Conditions: PAIS, Neonatal Stroke | Phase 2 | Status: UNKNOWN